• Home
  • Licensing
  • Browse All

All Available Technologies

Using the mutated version of herpes simplex virus-1 (HSV1) to target and terminate CD133+ cancer stem cells.

Category(s):
Subcategory(s):

Novel acetylcholinesterase (AChE) inhibitors for the symptomatic treatment of Alzheimer's disease.

Category(s):
Subcategory(s):

The present invention involves compounds that that demonstrate predominant activity against replicating Mtb, non-replicating Mtb, or both replicating and non-replicating Mtb. 

Category(s):
Subcategory(s):

The invention involves the successful development of a first-in-class, potent, not generally cytotoxic, chemical probe, that selectively activates the apoptotic but not the adaptive arm of the UPR.

Category(s):
Subcategory(s):

This invention uses microRNA biomarkers to detect or diagnose Barrett's esophagus, detect dysplasia in Barrett's esophagus, and detect early onset of esophageal cancer.

Category(s):
Subcategory(s):

This invention is aimed at delaying the tumor growth in breast and ovarian cancers by increasing BRCA1 protein expression.

Category(s):
Subcategory(s):

This invention offers a novel approach to the prevention of lung cancer via the selective inhibition of the enzyme in the human lung that activates tobacco compounds into carcinogens.  

Category(s):
Subcategory(s):

Implantable biomaterial for promoting bone and cartilage regeneration in joints following articular cartilage injury, a leading cause of advanced osteoarthritis. 

Subcategory(s):

The invention is a novel synthesis procedure to create hydrogels with mechanical properties desirable for musculoskeletal tissue engineering.

Subcategory(s):

Based on precision drug delivery technologies, ConocoPhilips and KU have jointly developed a patented technology using polyelectrolyte complex (PEC) nanoparticles to entrap/protect and delay the release of oil and gas field chemicals.

Category(s):
Subcategory(s):

Pages


Events
KU Today